logo
Plus   Neg
Share
Email

Chemours Lifts FY18 Outlook

Chemours Co. (CC), Monday lifted its outlook for the full year, as it continues to see "robust demand" for its products.

Chemours, the chemical company that was spun off from DuPont in 2015, now expects adjusted earnings per share of $4.95 to $5.60 per share. Analysts polled by Thomson Reuters currently estimate earnings of $5.41 per share for the full year.

The company expects 2018 adjusted EBITDA at the high end of a previously announced range between $1.7 billion and $1.85 billion.

Chemours President and CEO Mark Vergnano said: "We ended 2017 with incredible momentum in all of our businesses and strong demand signals for both Fluoroproducts and Titanium Technologies. With nearly one quarter behind us, we continue to see robust demand for Ti-Pure™ titanium dioxide alongside a more favorable than expected demand and pricing backdrop for our Fluoroproducts segment."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AMC Entertainment Holdings, Inc., the world's largest theatre chain, said it has substantial doubt in its ability to continue its business as theaters across the world remain closed for months now following coronavirus or Covid-19 pandemic. In a regulatory filing, the company said it is "generating effectively no revenue", and that additional capital, if needed, may not be available. Apple is tracking iPhones that were stolen from its retail stores in recent days during the civil unrest, according to reports citing a warning message popping up on the stolen iPhones. Four current and former senior executives from two major broiler chicken producers, including Pilgrim's Pride CEO Jayson Penn, have been indicted for price fixing.
RELATED NEWS
Follow RTT